Table of Content

1. Preface

1.1. Report Scope and Market Segmentation

1.2. Research Highlights


2. Assumptions and Research Methodology

2.1. Assumptions

2.2. Research Methodology


3. Executive Summary

3.1. Global Systemic Lupus Erythematosus Treatment Market Snapshot


4. Market Overview

4.1. Product Overview

4.2. Key Industry Events

4.3. Market Dynamics

4.3.1. Drivers and Restraints Snapshot Analysis

4.3.2. Drivers

4.3.3. Restraints

4.3.4. Opportunities

4.4. Global Systemic Lupus Erythematosus Treatment Market Revenue Projection

4.5. Global Systemic Lupus Erythematosus Treatment Market Outlook


5. Market Outlook

5.1. Key Mergers & Acquisitions

5.2. Pipeline Analysis

5.3. Disease Prevalence & Incidence Rate Globally with Key Countries


6. Global Systemic Lupus Erythematosus Treatment Market Analysis, by Drug

6.1. Introduction

6.2. Global Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Drug

6.3. Global Systemic Lupus Erythematosus Treatment Market Forecast, by Drug

6.3.1. Antimalarial Drugs

6.3.1.1. Chloroquine

6.3.1.2. Hydrochloroquine

6.3.2. Non-steroidal Anti-inflammatory Drugs (NSAIDS)

6.3.2.1. Ibuprofen

6.3.2.2. Naproxen

6.3.2.3. Others

6.3.3. Corticosteroids

6.3.3.1. Prednisone

6.3.3.2. Hydrocortisone

6.3.3.3. Dexamethasone

6.3.3.4. Others

6.3.4. Immunosuppressive Drugs

6.3.4.1. Azathioprine

6.3.4.2. Cyclophosphamide

6.3.4.3. Methotrexate

6.3.4.4. Others

6.3.5. Others (Biologics, B-cell Modulators, etc.)


7. Global Systemic Lupus Erythematosus Treatment Market Analysis, by Mode of Delivery

7.1. Introduction

7.2. Global Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Mode of Delivery

7.3. Global Systemic Lupus Erythematosus Treatment Market Forecast, by Mode of Delivery

7.3.1. Intravenous

7.3.2. Subcutaneous

7.3.3. Oral

7.4. Global Systemic Lupus Erythematosus Treatment Market Analysis, by Mode of Delivery


8. Global Systemic Lupus Erythematosus Treatment Market Analysis, by Distribution Channel

8.1. Introduction

8.2. Global Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel

8.3. Global Systemic Lupus Erythematosus Treatment Market Forecast, by Distribution Channel

8.3.1. Hospital Pharmacies

8.3.2. Retail Pharmacies

8.3.3. Online Sales

8.4. Global Systemic Lupus Erythematosus Treatment Market Analysis, by Distribution Channel


9. Global Systemic Lupus Erythematosus Treatment Market Analysis, by Region

9.1. Global Systemic Lupus Erythematosus Treatment Market Scenario, by Country

9.2. Global Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Region

9.3. Global Systemic Lupus Erythematosus Treatment Market Forecast, by Region

9.3.1. North America

9.3.2. Europe

9.3.3. Asia Pacific

9.3.4. Latin America

9.3.5. Middle East & Africa


10. North America Systemic Lupus Erythematosus Treatment Market Analysis

10.1. Key Findings

10.2. North America Systemic Lupus Erythematosus Treatment Market Overview

10.3. North America Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Country

10.4. North America Systemic Lupus Erythematosus Treatment Market Forecast, by Country

10.4.1. U.S.

10.4.2. Canada

10.5. North America Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Drug

10.6. North America Systemic Lupus Erythematosus Treatment Market Forecast, by Drug

10.6.1. Antimalarial Drugs

10.6.1.1. Chloroquine

10.6.1.2. Hydrochloroquine

10.6.2. Non-steroidal Anti-inflammatory Drugs (NSAIDS)

10.6.2.1. Ibuprofen

10.6.2.2. Naproxen

10.6.2.3. Others

10.6.3. Corticosteroids

10.6.3.1. Prednisone

10.6.3.2. Hydrocortisone

10.6.3.3. Dexamethasone

10.6.3.4. Others

10.6.4. Immunosuppressive Drugs

10.6.4.1. Azathioprine

10.6.4.2. Cyclophosphamide

10.6.4.3. Methotrexate

10.6.4.4. Others

10.6.5. Others (Biologics, B-cell Modulators, etc.)

10.7. North America Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Mode of Delivery

10.8. North America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Mode of Delivery

10.8.1. Intravenous

10.8.2. Subcutaneous

10.8.3. Oral

10.9. North America Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel

10.10. North America Systemic Lupus Erythematosus Treatment Market Forecast, by Distribution Channel

10.10.1. Hospital Pharmacies

10.10.2. Retail Pharmacies

10.10.3. Online Sales


11. Europe Systemic Lupus Erythematosus Treatment Market Analysis

11.1. Key Findings

11.2. Europe Systemic Lupus Erythematosus Treatment Market Overview

11.3. Europe Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

11.4. Europe Systemic Lupus Erythematosus Treatment Market Forecast, by Country/Sub-region

11.4.1. Germany

11.4.2. U.K.

11.4.3. France

11.4.4. Spain

11.4.5. Italy

11.4.6. Rest of Europe

11.5. Europe Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Drug

11.6. Europe Systemic Lupus Erythematosus Treatment Market Forecast, by Drug

11.6.1. Antimalarial Drugs

11.6.1.1. Chloroquine

11.6.1.2. Hydrochloroquine

11.6.2. Non-steroidal Anti-inflammatory Drugs (NSAIDS)

11.6.2.1. Ibuprofen

11.6.2.2. Naproxen

11.6.2.3. Others

11.6.3. Corticosteroids

11.6.3.1. Prednisone

11.6.3.2. Hydrocortisone

11.6.3.3. Dexamethasone

11.6.3.4. Others

11.6.4. Immunosuppressive Drugs

11.6.4.1. Azathioprine

11.6.4.2. Cyclophosphamide

11.6.4.3. Methotrexate

11.6.4.4. Others

11.6.5. Others (Biologics, B-cell Modulators, etc.)

11.7. Europe Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Mode of Delivery

11.8. Europe Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Mode of Delivery

11.8.1. Intravenous

11.8.2. Subcutaneous

11.8.3. Oral

11.9. Europe Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel

11.10. Europe Systemic Lupus Erythematosus Treatment Market Forecast, by Distribution Channel

11.10.1. Hospital Pharmacies

11.10.2. Retail Pharmacies

11.10.3. Online Sales

12. Asia Pacific Systemic Lupus Erythematosus Treatment Market Analysis

12.1. Key Findings

12.2. Asia Pacific Systemic Lupus Erythematosus Treatment Market Overview

12.3. Asia Pacific Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

12.4. Asia Pacific Systemic Lupus Erythematosus Treatment Market Forecast, by Country/Sub-region

12.4.1. Japan

12.4.2. China

12.4.3. India

12.4.4. Australia & New Zealand

12.4.5. Rest of Asia Pacific

12.5. Asia Pacific Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Drug

12.6. Asia Pacific Systemic Lupus Erythematosus Treatment Market Forecast, by Drug

12.6.1. Antimalarial Drugs

12.6.1.1. Chloroquine

12.6.1.2. Hydrochloroquine

12.6.2. Non-steroidal Anti-inflammatory Drugs (NSAIDS)

12.6.2.1. Ibuprofen

12.6.2.2. Naproxen

12.6.2.3. Others

12.6.3. Corticosteroids

12.6.3.1. Prednisone

12.6.3.2. Hydrocortisone

12.6.3.3. Dexamethasone

12.6.3.4. Others

12.6.4. Immunosuppressive Drugs

12.6.4.1. Azathioprine

12.6.4.2. Cyclophosphamide

12.6.4.3. Methotrexate

12.6.4.4. Others

12.6.5. Others (Biologics, B-cell Modulators, etc.)

12.7. Asia Pacific Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Mode of Delivery

12.8. Asia Pacific Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Mode of Delivery

12.8.1. Intravenous

12.8.2. Subcutaneous

12.8.3. Oral

12.9. Asia Pacific Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel

12.10. Asia Pacific Systemic Lupus Erythematosus Treatment Market Forecast, by Distribution Channel

12.10.1. Hospital Pharmacies

12.10.2. Retail Pharmacies

12.10.3. Online Sales


13. Latin America Systemic Lupus Erythematosus Treatment Market Analysis

13.1. Key Findings

13.2. Latin America Systemic Lupus Erythematosus Treatment Market Overview

13.3. Latin America Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

13.4. Latin America Systemic Lupus Erythematosus Treatment Market Forecast, by Country/Sub-region

13.4.1. Brazil

13.4.2. Mexico

13.4.3. Rest of Latin America

13.5. Latin America Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Drug

13.6. Latin America Systemic Lupus Erythematosus Treatment Market Forecast, by Drug

13.6.1. Antimalarial Drugs

13.6.1.1. Chloroquine

13.6.1.2. Hydrochloroquine

13.6.2. Non-steroidal Anti-inflammatory Drugs (NSAIDS)

13.6.2.1. Ibuprofen

13.6.2.2. Naproxen

13.6.2.3. Others

13.6.3. Corticosteroids

13.6.3.1. Prednisone

13.6.3.2. Hydrocortisone

13.6.3.3. Dexamethasone

13.6.3.4. Others

13.6.4. Immunosuppressive Drugs

13.6.4.1. Azathioprine

13.6.4.2. Cyclophosphamide

13.6.4.3. Methotrexate

13.6.4.4. Others

13.6.5. Others (Biologics, B-cell Modulators, etc.)

13.7. Latin America Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Mode of Delivery

13.8. Latin America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Mode of Delivery

13.8.1. Intravenous

13.8.2. Subcutaneous

13.8.3. Oral

13.9. Latin America Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel

13.10. Latin America Systemic Lupus Erythematosus Treatment Market Forecast, by Distribution Channel

13.10.1. Hospital Pharmacies

13.10.2. Retail Pharmacies

13.10.3. Online Sales


14. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Analysis

14.1. Key Findings

14.2. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Overview

14.3. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

14.4. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Forecast, by Country/Sub-region

14.4.1. GCC Countries

14.4.2. South Africa

14.4.3. Rest of Middle East & Africa

14.5. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Drug

14.6. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Forecast, by Drug

14.6.1. Antimalarial Drugs

14.6.1.1. Chloroquine

14.6.1.2. Hydrochloroquine

14.6.2. Non-steroidal Anti-inflammatory Drugs (NSAIDS)

14.6.2.1. Ibuprofen

14.6.2.2. Naproxen

14.6.2.3. Others

14.6.3. Corticosteroids

14.6.3.1. Prednisone

14.6.3.2. Hydrocortisone

14.6.3.3. Dexamethasone

14.6.3.4. Others

14.6.4. Immunosuppressive Drugs

14.6.4.1. Azathioprine

14.6.4.2. Cyclophosphamide

14.6.4.3. Methotrexate

14.6.4.4. Others

14.6.5. Others (Biologics, B-cell Modulators, etc.)

14.7. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Mode of Delivery

14.8. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Mode of Delivery

14.8.1. Intravenous

14.8.2. Subcutaneous

14.8.3. Oral

14.9. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel

14.10. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Forecast, by Distribution Channel

14.10.1. Hospital Pharmacies

14.10.2. Retail Pharmacies

14.10.3. Online Sales


15. Competitive Landscape

15.1. Competition Matrix

15.2. Company Profile

15.2.1. GlaxoSmithKline plc

15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.1.2. Financial Overview

15.2.1.3. Product Portfolio

15.2.1.4. SWOT Analysis

15.2.1.5. Strategic Overview

15.2.2. F. Hoffmann-La Roche Ltd.

15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.2.2. Financial Overview

15.2.2.3. Product Portfolio

15.2.2.4. SWOT Analysis

15.2.2.5. Strategic Overview

15.2.3. Pfizer, Inc.

15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.3.2. Financial Overview

15.2.3.3. Product Portfolio

15.2.3.4. SWOT Analysis

15.2.3.5. Strategic Overview

15.2.4. AstraZeneca plc

15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.4.2. Financial Overview

15.2.4.3. Product Portfolio

15.2.4.4. SWOT Analysis

15.2.4.5. Strategic Overview

15.2.5. Merck & Co., Inc.

15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.5.2. Financial Overview

15.2.5.3. Product Portfolio

15.2.5.4. SWOT Analysis

15.2.5.5. Strategic Overview

15.2.6. Bristol-Myers Squibb Company

15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.6.2. Financial Overview

15.2.6.3. Product Portfolio

15.2.6.4. SWOT Analysis

15.2.6.5. Strategic Overview

15.2.7. Anthera Pharmaceuticals, Inc.

15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.7.2. Financial Overview

15.2.7.3. Product Portfolio

15.2.7.4. SWOT Analysis

15.2.7.5. Strategic Overview

15.2.8. ImmuPharma PLC

15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.8.2. Product Portfolio

15.2.8.3. SWOT Analysis

15.2.8.4. Strategic Overview

15.2.9. Aurinia Pharmaceuticals, Inc.

15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.9.2. Product Portfolio

15.2.9.3. SWOT Analysis

15.2.9.4. Strategic Overview



List of Figures



Figure 01: Global Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027

Figure 02: Global Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) and Forecast, 2019–2027

Figure 03: Global Systemic Lupus Erythematosus Treatment Market Value Share (%), by Drug, 2018

Figure 04: Global Systemic Lupus Erythematosus Treatment Market Value Share (%), by Mode of Delivery, 2018

Figure 05: Global Systemic Lupus Erythematosus Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 06: Global Systemic Lupus Erythematosus Treatment Market Value Share (%), by Region, 2018

Figure 07: Global Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Drug, 2018 and 2027

Figure 08: Global Systemic Lupus Erythematosus Treatment Market Attractiveness, by Drug, 2019–2027

Figure 09: Global Systemic Lupus Erythematosus Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Antimalarial Drugs, 2017–2027

Figure 10: Global Systemic Lupus Erythematosus Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Non-steroidal Anti-inflammatory Drugs (NSAIDS), 2017–2027

Figure 11: Global Systemic Lupus Erythematosus Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Corticosteroids, 2017–2027

Figure 12: Global Systemic Lupus Erythematosus Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Immunosuppressive Drugs, 2017–2027

Figure 13: Global Systemic Lupus Erythematosus Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others (Biologics, B-cell Modulators, etc.), 2017–2027

Figure 14: Global Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Mode of Delivery, 2018 and 2027

Figure 15: Global Systemic Lupus Erythematosus Treatment Market Attractiveness, by Mode of Delivery, 2019–2027

Figure 16: Global Systemic Lupus Erythematosus Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Intravenous, 2017–2027

Figure 17: Global Systemic Lupus Erythematosus Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Subcutoneous, 2017–2027

Figure 18: Global Systemic Lupus Erythematosus Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oral, 2017–2027

Figure 19: Global Systemic Lupus Erythematosus Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 20: Global Systemic Lupus Erythematosus Treatment Market Attractiveness, by Distribution Channel, 2019–2027

Figure 21: Global Systemic Lupus Erythematosus Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2017–2027

Figure 22: Global Systemic Lupus Erythematosus Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2017–2027

Figure 23: Global Systemic Lupus Erythematosus Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Sales, 2017–2027

Figure 24: Global Systemic Lupus Erythematosus Treatment Market Value Share, by Region, 2018 and 2027

Figure 25: Global Systemic Lupus Erythematosus Treatment Market Attractiveness, by Region, 2019–2027

Figure 26: North America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 27: North America Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Country, 2018 and 2027

Figure 28: North America Systemic Lupus Erythematosus Treatment Market Attractiveness, by Country, 2019–2027

Figure 29: North America Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Drug, 2018 and 2027

Figure 30: North America Systemic Lupus Erythematosus Treatment Market Attractiveness, by Drug, 2019–2027

Figure 31: North America Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Mode of Delivery, 2018 and 2027

Figure 32: North America Systemic Lupus Erythematosus Treatment Market Attractiveness, by Mode of Delivery, 2019–2027

Figure 33: North America Systemic Lupus Erythematosus Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 34: North America Systemic Lupus Erythematosus Treatment Market Attractiveness, by Distribution Channel, 2019–2027

Figure 35: Europe Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 36: Europe Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 37: Europe Systemic Lupus Erythematosus Treatment Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 38: Europe Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Drug, 2018 and 2027

Figure 39: Europe Systemic Lupus Erythematosus Treatment Market Attractiveness, by Drug, 2019–2027

Figure 40: Europe Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Mode of Delivery, 2018 and 2027

Figure 41: Europe Systemic Lupus Erythematosus Treatment Market Attractiveness, by Mode of Delivery, 2019–2027

Figure 42: Europe Systemic Lupus Erythematosus Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 43: Europe Systemic Lupus Erythematosus Treatment Market Attractiveness, by Distribution Channel, 2019–2027

Figure 44: Asia Pacific Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 45: Asia Pacific Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 46: Asia Pacific Systemic Lupus Erythematosus Treatment Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 47: Asia Pacific Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Drug, 2018 and 2027

Figure 48: Asia Pacific Systemic Lupus Erythematosus Treatment Market Attractiveness, by Drug, 2019–2027

Figure 49: Asia Pacific Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Mode of Delivery, 2018 and 2027

Figure 50: Asia Pacific Systemic Lupus Erythematosus Treatment Market Attractiveness, by Mode of Delivery, 2019–2027

Figure 51: Asia Pacific Systemic Lupus Erythematosus Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 52: Asia Pacific Systemic Lupus Erythematosus Treatment Market Attractiveness, by Distribution Channel, 2019–2027

Figure 53: Latin America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 54: Latin America Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 55: Latin America Systemic Lupus Erythematosus Treatment Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 56: Latin America Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Drug, 2018 and 2027

Figure 57: Latin America Systemic Lupus Erythematosus Treatment Market Attractiveness, by Drug, 2019–2027

Figure 58: Latin America Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Mode of Delivery, 2018 and 2027

Figure 59: Latin America Systemic Lupus Erythematosus Treatment Market Attractiveness, by Mode of Delivery, 2019–2027

Figure 60: Latin America Systemic Lupus Erythematosus Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 61: Latin America Systemic Lupus Erythematosus Treatment Market Attractiveness, by Distribution Channel, 2019–2027

Figure 62: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 63: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 64: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 65: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Drug, 2018 and 2027

Figure 66: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Attractiveness, by Drug, 2019–2027

Figure 67: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value Share Analysis, by Mode of Delivery, 2018 and 2027

Figure 68: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Attractiveness, by Mode of Delivery, 2019–2027

Figure 69: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 70: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Attractiveness, by Distribution Channel, 2019–2027


List of Tables



Table 01: Global Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Drug, 2017–2027

Table 02: Global Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Antimalarial Drugs, 2017–2027

Table 03: Global Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Non-steroidal Anti-inflammatory Drugs (NSAIDS), 2017–2027

Table 04: Global Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Corticosteroids, 2017–2027

Table 05: Global Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Immunosuppressive Drugs, 2017–2027

Table 06: Global Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Mode of Delivery, 2017–2027

Table 07: Global Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 08: Global Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 09: North America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 10: North America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Drug, 2017–2027

Table 11: North America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Antimalarial Drugs, 2017–2027

Table 12: North America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Non-steroidal Anti-inflammatory Drugs (NSAIDS), 2017–2027

Table 13: North America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Corticosteroids, 2017–2027

Table 14: North America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Immunosuppressive Drugs, 2017–2027

Table 15: North America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Mode of Delivery, 2017–2027

Table 16: North America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 17: Europe Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 18: Europe Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Drug, 2017–2027

Table 19: Europe Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Antimalarial Drugs, 2017–2027

Table 20: Europe Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Non-steroidal Anti-inflammatory Drugs (NSAIDS), 2017–2027

Table 21: Europe Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Corticosteroids, 2017–2027

Table 22: Europe Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Immunosuppressive Drugs, 2017–2027

Table 23: Europe Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Mode of Delivery, 2017–2027

Table 24: Europe Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 25: Asia Pacific Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 26: Asia Pacific Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Drug, 2017–2027

Table 27: Asia Pacific Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Antimalarial Drugs, 2017–2027

Table 28: Asia Pacific Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Non-steroidal Anti-inflammatory Drugs (NSAIDS), 2017–2027

Table 29: Asia Pacific Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Corticosteroids, 2017–2027

Table 30: Asia Pacific Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Immunosuppressive Drugs, 2017–2027

Table 31: Asia Pacific Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Mode of Delivery, 2017–2027

Table 32: Asia Pacific Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 33: Latin America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 34: Latin America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Drug, 2017–2027

Table 35: Latin America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Antimalarial Drugs, 2017–2027

Table 36: Latin America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Non-steroidal Anti-inflammatory Drugs (NSAIDS), 2017–2027

Table 37: Latin America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Corticosteroids, 2017–2027

Table 38: Latin America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Immunosuppressive Drugs, 2017–2027

Table 39: Latin America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Mode of Delivery, 2017–2027

Table 40: Latin America Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 41: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 42: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Drug, 2017–2027

Table 43: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Antimalarial Drugs, 2017–2027

Table 44: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Non-steroidal Anti-inflammatory Drugs (NSAIDS), 2017–2027

Table 45: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Corticosteroids, 2017–2027

Table 46: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Immunosuppressive Drugs, 2017–2027

Table 47: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Mode of Delivery, 2017–2027

Table 48: Middle East & Africa Systemic Lupus Erythematosus Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027